Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | CPRT | CTAS |
|---|---|---|
| Price | $27.07 | $194.95 |
| Change today | ▼ 0.79% | ▼ 0.06% |
| Market cap | $25.07B | $77.89B |
| Return, 3 months | – | +12.2% |
| Return, year to date | – | +4.4% |
| Return, 1 year | – | -3.3% |
| P/E (TTM) | 17.5 | 38.5 |
| P/B | 2.8 | 15.0 |
| P/E percentile vs own 5y | 1st | 44th |
| Dividend yield | – | 0.96% |
| Revenue growth (YoY, latest qtr) | +2.4% | +8.9% |
| Net profit growth (YoY) | -17.3% | +14.0% |
| Gross margin | 44.7% | 50.7% |
| Operating margin | 35.4% | 23.3% |
| Net margin | 31.8% | 17.7% |
| Return on equity | 16.2% | 40.6% |
| Analyst target vs. price | +39.2% | +13.4% |
| Analyst buy share | 57% | 75% |
| RSI (14) | – | 43 |
| 30-day volatility | – | 15.1% |
| Max drawdown, 1 year | – | -20.0% |
| Trend read | – | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
